Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17617139 | 1.00 | HCAR2 (0.40) | HCAR2ALDH1A1LMNAESR1CHRM1 | |
| SCHEMBL805650 | 1.00 | HCAR2 (0.40) | HCAR2ALDH1A1LMNAESR1CHRM1 | |
| SCHEMBL13667079 | 0.90 | ALDH1A1 (0.37) | ALDH1A1LMNATSHRHSD17B10CA1 | |
| SCHEMBL9893691 | 0.87 | HSD17B10 (0.40) | HCAR2ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL310458 | 0.86 | ALDH1A1 (0.54) | HCAR2ALDH1A1LMNAESR1TSHR | |
| SCHEMBL13541256 | 0.86 | ALDH1A1 (0.54) | HCAR2ALDH1A1LMNAESR1TSHR | |
| SCHEMBL8954874 | 0.86 | ALDH1A1 (0.54) | HCAR2ALDH1A1LMNAESR1TSHR | |
| SCHEMBL3914212 | 0.84 | DGKA (0.53) | ALDH1A1LMNATSHRTDP1ATM | |
| SCHEMBL2418446 | 0.84 | NAAA (0.52) | HCAR2ALDH1A1LMNATSHRCA1 | |
| SCHEMBL805653 | 0.84 | NAAA (0.52) | HCAR2ALDH1A1LMNATSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
| US-5496580-A | ADDING ESTERS OF 2-METHYLBUTYRIC ACID | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1996-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | HCAR2 4403/4885ALDH1A1 236/4885LMNA 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.